Food Materials Comprising Filamentous Fungal Particles and Membrane Bioreactor Design
US-2024041084-A1 · Feb 8, 2024 · US
Method for producing fermented milk having high angiotensin converting enzyme inhibitory activity and method for producing physiologically active peptide
US10780127B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10780127-B2 |
| Application number | US-201716311827-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 22, 2017 |
| Priority date | Jun 23, 2016 |
| Publication date | Sep 22, 2020 |
| Grant date | Sep 22, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides fermented milk having a high angiotensin converting enzyme inhibition activity, a high hypotensive activity and/or a high stroke-preventing activity. The present invention also provides a method for producing fermented milk having a high angiotensin converting enzyme inhibition activity, a high hypotensive activity and/or a high stroke-preventing activity and a method for producing Tyr-Pro, each of which is characterized by comprising fermenting milk with a mushroom.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for producing fermented milk having an angiotensin converting enzyme inhibitory activity, a hypotensive activity, and/or a stroke prevention activity, which comprises fermenting milk by culturing milk with a mushroom wherein the mushroom belongs to Gloeophyllaceae family, Polyporaceae family, or Corticiaceae family. 2. The method according to claim 1 , wherein the mushroom is a mushroom belonging to Neolentinus genus, Trametes genus, or Peniophora genus. 3. The method according to claim 2 , wherein the mushroom is a mushroom belonging to Neolentinus genus or Peniophora genus. 4. The method according to claim 1 , wherein the milk is cow milk or skim milk. 5. Fermented milk having an angiotensin converting enzyme inhibitory activity, a hypotensive activity, and/or a stroke prevention activity, which is obtained by the method according to claim 1 . 6. A method for producing a food or drink having an angiotensin converting enzyme inhibitory activity, a hypotensive activity, and/or a stroke prevention activity, which comprises including the fermented milk according to claim 5 in the food or drink. 7. A method for producing a pharmaceutical composition for angiotensin converting enzyme inhibition, hypotension, and/or stroke prevention, which comprises including the fermented milk according to claim 5 in the composition. 8. A method for producing Tyr-Pro, which comprises fermenting milk by culturing milk with a mushroom. 9. The method according to claim 8 , wherein the mushroom is a mushroom belonging to Gloeophyllaceae family, Polyporaceae family, or Corticiaceae family. 10. The method according to claim 9 , wherein the mushroom is a mushroom belonging to Neolentinus genus, Trametes genus, or Peniophora genus. 11. The method according to claim 10 , wherein the mushroom is a mushroom belonging to Neolentinus genus or Peniophora genus. 12. The method according to claim 8 , wherein the milk is cow milk or the skim milk.
Assignees
Inventors
Classifications
Basidiomycota, e.g. Cryptococcus · CPC title
- A23C9/127Primary
using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss (A23C9/13 takes precedence) · CPC title
using additives · CPC title
- A61K35/20Primary
Milk; Whey; Colostrum · CPC title
having a known sequence of two or more amino acids, e.g. glutathione · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10780127B2 cover?
- The present invention provides fermented milk having a high angiotensin converting enzyme inhibition activity, a high hypotensive activity and/or a high stroke-preventing activity. The present invention also provides a method for producing fermented milk having a high angiotensin converting enzyme inhibition activity, a high hypotensive activity and/or a high stroke-preventing activity and a me…
- Who is the assignee on this patent?
- Nat Univ Corp Tottori Univ, National Univ Corporation Shimane Univ
- What technology area does this patent fall under?
- Primary CPC classification A23C9/127. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).